« Previous
Next »
Leukemia Research
Volume 33, Issue 12
, Pages 1696-1698
, December 2009
Differential regulation of 11β-hydroxysteroid dehydrogenase-1 by dexamethasone in glucocorticoid-sensitive and -resistant childhood lymphoblastic leukemia
References
- . 11β-Hydroxysteroid dehydrogenases: changing glucocorticoid action. Curr Opin Pharmacol. 2004;4:597–602
- . In vitro drug sensitivity testing can predict induction failure and early relapse of childhood acute lymphoblastic leukemia. Blood. 1997;89:2959–2965
- . Role of glucocorticoid receptor and CCAAT/enhancer-binding protein α in the feed-forward induction of 11β-hydroxysteroid dehydrogenase type 1 expression by cortisol in human amnion fibroblasts. J Endocrinol. 2007;195:241–253
- Glucocorticoid regulation of the promoter of 11β-hydroxysteroid dehydrogenase type 1 is indirect and requires C/EBPβ. Mol Endocrinol. 2008;22:2049–2060
- . Limited expression of C/EBP family proteins during B lymphocyte development. Negative regulator Ig/EBP predominates early and activator NF-IL-6 is induced later. J Immunol. 1994;153:5049–5058
- Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab. 2001;86:1418–1421
- A transgenic model of visceral obesity and the metabolic syndrome. Science. 2001;294:2166–2170
- . Glucocorticoid-induced cell death requires autoinduction of glucocorticoid receptor expression in human leukemic T cells. Cancer Res. 1999;59:1378–1385
☆ Presented in abstract form at the 90th Annual Meeting of the Endocrine Society, 17 June 2008.
PII: S0145-2126(09)00193-3
doi: 10.1016/j.leukres.2009.04.016
© 2009 Elsevier Ltd. All rights reserved.
« Previous
Next »
Leukemia Research
Volume 33, Issue 12
, Pages 1696-1698
, December 2009
